cladribine has been researched along with Neoplasms, Vascular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inamoto, Y; Ito, M; Kodera, Y; Kuwatsuka, Y; Miyamura, K; Murase, T; Oba, T; Suzuki, R; Terakura, S; Tokunaga, M; Tsujimura, A | 1 |
1 other study(ies) available for cladribine and Neoplasms, Vascular
Article | Year |
---|---|
[Successful salvage therapy with cladribine and rituximab for a patient with a relapsed Asian variant of intravascular large B-cell lymphoma].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Administration Schedule; Humans; Lymphoma, B-Cell; Male; Recurrence; Rituximab; Salvage Therapy; Vascular Neoplasms | 2006 |